Marshall Wace North America’s NeoGenomics NEO Stock Holding History

Marshall Wace North America’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,225	Closed	-$81K	–	1484
2019 Q3	$81K	Sell	4,225 -232,013	-98%	-$5.44M	﹤0.01%	1092
2019 Q2	$5.18M	Buy	236,238 +27,432	+13%	+$602K	0.03%	353
2019 Q1	$4.27M	Sell	208,806 -28,652	-12%	-$498K	0.03%	348
2018 Q4	$3M	Buy	237,458 +17,399	+8%	+$259K	0.03%	350
2018 Q3	$3.38M	Buy	220,059 +934	+0.4%	+$12.9K	0.02%	388
2018 Q2	$2.87M	Buy	219,125 +159,737	+269%	+$1.76M	0.02%	671
2018 Q1	$485K	Buy	+59,388	New	+$481K	﹤0.01%	1158

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Marshall Wace North America's NEO Position: Q4 2019 in Review

Marshall Wace North America sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 4,225 shares — an estimated $81K sold.

Marshall Wace North America first reported a position in NEO in Q1 2018 and held it in 7 quarters. The position peaked at $5.18M in Q2 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

Marshall Wace North America reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
Marshall Wace North America sold 4,225 NeoGenomics shares in Q4 2019, an estimated $81K.
Marshall Wace North America first reported a position in NeoGenomics in Q1 2018 and held it in 7 quarters.
Marshall Wace North America's NeoGenomics position peaked at $5.18M in Q2 2019.
261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.